TY - JOUR
T1 - Pathogenesis of myelofibrosis with myeloid metaplasia
T2 - Lessons from mouse models of the disease
AU - Vannucchi, Alessandro M.
AU - Migliaccio, Anna Rita
AU - Paoletti, Francesco
AU - Chagraoui, Hedia
AU - Wendling, Françoise
N1 - Funding Information:
Supported in part by funds from Associazione Italiana per la Ricerca sul Cancro (AIRC), Milano; the Italian Health Council (MURST PRIN 2002, #06103241; 2003, #06488803); the Institut National de la Santé et de la Recherche Médicale, the Institut Gustave Roussy and the Ligue Nationale contre le Cancer “équipe labellisée 2000.”
PY - 2005/8
Y1 - 2005/8
N2 - The primary genetic lesion(s), as well as the biological processes responsible for the typical structural changes of the bone marrow microenvironment in idiopathic myelofibrosis, are still poorly understood, although a central role in disease pathogenesis has been attributed to the clonal proliferation and defective maturation of megakaryocytes. Two animal models of the disease have been described, that in the last few years significantly contributed to the elucidation of some of the pathogenetic steps of the human disease; these are represented by mice genetically modified to overexpress thrombopoietin and by knock-down mice with defective GATA-1 expression in megakaryocytes (GATA-1low mice). This review will outline these murine models, both characterized by extensive accumulation of megakaryocytes in hematopoietic tissues, and illustrate how they provided insights into the identification of some of the molecules and mechanisms responsible for the development of fibrosis and osteosclerosis that present major similarities with those observed in patients with idiopathic myelofibrosis.
AB - The primary genetic lesion(s), as well as the biological processes responsible for the typical structural changes of the bone marrow microenvironment in idiopathic myelofibrosis, are still poorly understood, although a central role in disease pathogenesis has been attributed to the clonal proliferation and defective maturation of megakaryocytes. Two animal models of the disease have been described, that in the last few years significantly contributed to the elucidation of some of the pathogenetic steps of the human disease; these are represented by mice genetically modified to overexpress thrombopoietin and by knock-down mice with defective GATA-1 expression in megakaryocytes (GATA-1low mice). This review will outline these murine models, both characterized by extensive accumulation of megakaryocytes in hematopoietic tissues, and illustrate how they provided insights into the identification of some of the molecules and mechanisms responsible for the development of fibrosis and osteosclerosis that present major similarities with those observed in patients with idiopathic myelofibrosis.
UR - https://www.scopus.com/pages/publications/23044445190
U2 - 10.1053/j.seminoncol.2005.04.008
DO - 10.1053/j.seminoncol.2005.04.008
M3 - Article
C2 - 16202682
AN - SCOPUS:23044445190
SN - 0093-7754
VL - 32
SP - 365
EP - 372
JO - Seminars in Oncology
JF - Seminars in Oncology
IS - 4
ER -